Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering Drugs
Not Applicable
Completed
- Conditions
- Cardiovascular Disease
- Interventions
- Procedure: Measurement of the Carotid Intima Media thicknessBiological: Blood sample testing for hs-CRP
- Registration Number
- NCT00970918
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of this study is to obtain the distribution of measurements of the intima media thickness of carotid arteries in people with high cardiovascular risk.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2609
Inclusion Criteria
- Provision of signed informed consent.
- Patients with at least two CVD risk factors but not on lipid-lowering agents
Exclusion Criteria
- Subjects with CHD, any conditions that may affect hs-CRP levels.
- Subjects on any lipid-lowering drug treatment within the last 3 months prior study entry.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 1 Measurement of the Carotid Intima Media thickness - 1 Blood sample testing for hs-CRP -
- Primary Outcome Measures
Name Time Method Measurement of Carotid Intima Media Thickness of people with high risk of cardiovascular disease but not on lipid lowering drugs IIMT measurements taken only once, either on Visit 1 or Visit 2 (time gap between V1 and V2 should be less than 3 months)
- Secondary Outcome Measures
Name Time Method Lipid profile of people with high risk of cardiovascular disease but not on lipid lowering drugs Blood sampling only once, either on Visit 1 or Visit 2 (time gap between V1 and V2 should be less than 3 months)
Trial Locations
- Locations (1)
Research Site
🇻🇳Hanoi, Vietnam